Fairvalue-Calculator Fairvalue-Calculator
EN DE

Ajanta Pharma Limited (AJANTPHARM) Fair Value & Analysis

Healthcare · IN · Market cap ₹399B

Price₹3,180
Fair Value₹1,666
Upside-47.6%
Quality97/100
Evidence: High Range ₹882.17 – ₹2,086

Fair value as of: Jun 29, 2026

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Ajanta Pharma Limited (AJANTPHARM) currently trades at ₹3,180, while our model-based Fair Value estimate is ₹1,666 — implying the stock looks roughly 47.6% overvalued today. We read business quality at 97/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, eye drops, dry powder suspension, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, gynaecology, nephrology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

Open the full interactive analysis →

Similar stocks

Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70% Swedish Orphan Biovitrum AB (SOBI) -54%

Frequently asked questions

Is Ajanta Pharma Limited (AJANTPHARM) undervalued?
As of Jun 29, 2026, our model estimates a fair value of ₹1,666 versus a price of ₹3,180 — about −48% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AJANTPHARM?
Our 21-model fair value for Ajanta Pharma Limited is ₹1,666 (as of Jun 29, 2026), built from audited fundamentals. The current price is ₹3,180.
What is the quality score of AJANTPHARM?
Ajanta Pharma Limited has a Quality Score of 97/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.